Lung Cancer Home > Doxorubicin

Doxorubicin is approved to treat breast cancer, lung cancer, and ovarian cancer, among other cancer types. It is administered intravenously at your healthcare provider's office, a hospital, or an infusion center. The dose your healthcare provider prescribes will depend on factors such as your weight, the type of cancer being treated, and other medical conditions. Possible side effects include weight gain, nausea, and hair loss.

What Is Doxorubicin?

Doxorubicin hydrochloride (Adriamycin®) is a prescription medication used to treat various types of cancer. This includes breast cancer, lung cancer, and ovarian cancer, to name a few. It is part of a group of chemotherapy medications called anthracyclines.
 
Please note that this article refers specifically to the nonliposomal formulation of doxorubicin. For more information about the liposomal formulation (Doxil®), see Liposomal Doxorubicin.
 
(Click What Is Doxorubicin Used For? for more information, including possible off-label uses.)
 

Side Effects of Doxorubicin

As with any medicine, side effects are possible with doxorubicin. Like most forms of chemotherapy, doxorubicin is capable of causing serious side effects.
 
Common side effects include but are not limited to:
 
(Click Side Effects of Doxorubicin to learn more, including potentially serious side effects you should report immediately to your healthcare provider.) 
 
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation
Advertisement


Topics

Medications

Quicklinks

Related Channels

eMedTV Links
Copyright © 2006-2017 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.